Acromegaly

Overview

What is Acromegaly

Acromegaly is a rare, chronic endocrine disorder caused by the excessive production of growth hormone (GH). Growth hormone is normally produced by the pituitary gland, a small gland located at the base of the brain. The most common cause of acromegaly is a non- cancerous tumor in or near the pituitary, called an adenoma, which may secrete growth hormone or other hormones. Excess growth hormone in Acromegaly can lead to serious complications, such as diabetes, increased stroke risk, osteoporosis, obstructive sleep apnea, migraines, and chronic pain due to abnormal tissue swelling and enlargement. Acromegaly in adults should not be confused with gigantism, or excessive height due to a childhood-onset pituitary disorder. In adults with new-onset acromegaly, height does not change, but growth in the hands and feet are typical. Increases in shoe or ring size are early symptoms patients experience. Enlarged heart muscles can contribute to cardiac complications, such as high blood pressure, irregular heartbeats, or heart failure. Acromegaly can also increase the chance of developing colon polyps, which can be become cancerous if not removed.1

Treatment for acromegaly is aimed at reducing or removing the pituitary tumor and may include surgery, radiation treatments, or medications to control excessive hormone release. Earlier treatment can help to reduce and reverse some complications associated with acromegaly.

How common is Acromegaly

Approximately 3,000 new cases of acromegaly are diagnosed each year in the United States, typically in adults 30-50 years of age.2 Men and women are affected equally. Nearly 25,000 Americans are living with acromegaly. Successful hormonal control often requires a combination of surgical, radiation, and/or medication therapy.3


Questions regarding your Acromegaly?

You can reach the Accredo Acromegaly care team, anytime, day or night, seven days a week by phone or online.

24-hour Customer Service Center

800-803-2523

  • 1Acromegaly. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Last reviewed January 2020, Accessed June 23, 2023. National Institute of Diabetes and Digestive and Kidney Diseases
  • 2Broder MS, et al. Incidence and Prevalence of Acromegaly in the United States: a Claims-based Analysis. Endocr Pract. 2016 Nov;22(11):1327-1335. doi: 10.4158/EP161397.OR.
  • 3Zahr R, Fleseriu M. Updates in Diagnosis and Treatment of Acromegaly. Eur Endocrinol. 2018 Sep;14(2):57-61. doi: 10.17925/EE.2018.14.2.57.